Aptamera is developing DNA aptamer-based cancer therapeutics.

History:

Aptamera was acquired by Antisoma in 2005.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Other US

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: